Cardiology · 2008 · 78 citations · 0 references
MedicineCardiologyInternal MedicineClinical CardiologyHemodynamic ManagementStructural Heart DiseaseCardiac Risk AssessmentCardiovascular DiseaseBlood PressureChagas CardiomyopathyChagas Heart DiseaseComplement Fixation TestsSystolic Blood Pressure
This prospective investigation was conducted in an attempt to identify noninvasive predictors of mortality for patients with Chagas’ heart disease through a multivariate stepwise logistic regression study. Fifty-six patients with a positive complement fixation test for Chagas’ disease were followed up at the Cardiomyopathy Clinic of our institution from April 1990 to April 1992. Patient age was 59 ± 17 years; 28 (50%) were male. Upon admission, 19 patients (33%) were in the New York Heart Association (NYHA) class III and 8 (14%) in the NYHA class IV. Systolic blood pressure was 125 ± 23 mm Hg, diastolic blood pressure 76 ± 11 mm Hg and resting heart rate 77 ± 11 beats/min. Forty patients (71%) were given digitalis and 39 (69%) angiotensin-converting enzyme inhibitors. Plasma Na+ was 140 ± 4 mEq/1, K+ was 4.34 ± 0.73 mEq/1 and creatinine level 1.34 ± 0.31 mg/l00 ml. Cardiomegaly was observed in the chest X-ray of 41 of 51 (79%) available patients. Atrial fibrillation was observed in the resting ECG of 24 of 54 (44%) available patients, premature ventricular contractions in 23 (41%), right bundle branch block in 26 (46%) and left anterior hemiblock in 26 (46%) patients. Echocardiography revealed a left ventricular ejection fraction of 0.45 ± 0.16, left ventricular systolic dimension of 51.23 ± 13.53 mm and left ventricular diastolic dimension of 62.94 ± 19 mm. Sixteen (28%) patients died during the 2-year study, 11 of them suddenly. By univariate analysis, left ventricular ejection fraction (p = 0.03), left ventricular diastolic dimension (p = 0.03), NYHA class IV (p = 0.0004) and digitalis use (p = 0.04) were found to be associated with mortality. In the multivariate model, however, only left ventricular ejection fraction was retained as an independent predictor of mortality. Actuarial survival was 75% for patients with left ventricular ejection fraction > 0.30, and 40% for patients with left ventricular ejection fraction < 0.30 (p = 0.03). We conclude that patients with Chagas’ heart disease having a left ventricular ejection fraction < 0.30 determined echocardio-graphically are at very high risk of dying.